Crossmark

Sacs R272C missense homozygous mice develop an ataxia phenotype

Crossref DOI link: https://doi.org/10.1186/s13041-019-0438-3

Published Online: 2019-03-12

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Larivière, Roxanne

Sgarioto, Nicolas

Márquez, Brenda Toscano

Gaudet, Rébecca

Choquet, Karine

McKinney, R. Anne

Watt, Alanna J.

Brais, Bernard https://orcid.org/0000-0003-1394-3561
Funding

Funding for this research was provided by:

Canadian Institutes of Health Research Emerging team grant on rare diseases: Translating basic biology to enhanced patient care (126526)

Fondation de l'Ataxie de Charlevoix-Saguenay

Fonds de Recherche du Québec - Santé
License Information

Text and Data Mining valid from 2019-03-12
More Information

Article History

Received: 19 June 2018

Accepted: 25 February 2019

First Online: 12 March 2019

Ethics approval

: All experiments were performed according to good practice of handling laboratory animals consistent with the Canadian Council on Animal Care and approved by the University Animal Care and MNI Animal Care committees. Studies using human cell lines were approved by the institutional review board of the Montreal Neurological Institute and with McGill University Research Ethics Board Committee.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.